Navigation Links
Zi Xiu Tang Success, LLC Issues Voluntary Nationwide Recall of Classic Zi Xiu Tang Bee Pollen Capsules and Ultimate Formula Capsules due to Undeclared Sibutramine
Date:10/29/2012

TREXLERTOWN, Pa., Oct. 29, 2012 /PRNewswire-iReach/ -- Zi Xiu Tang Success, LLC is voluntarily recalling four lots of Classic Zi Xiu Tang Bee Pollen Capsules, and three lots of Ultimate Formula Capsules to the consumer level.  These products have been found to contain undeclared Sibutramine. Sibutramine was a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, making these products unapproved new drugs.

Products containing Sibutramine pose a threat to consumers because Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.  These products may also interact in life threatening ways with other medications a consumer may be taking.  The company has not received any reports of adverse events related to this recall.  The recall was initiated after discovering that Sibutramine was included as an ingredient by the manufacturer.

The Classic Zi Xiu Tang Bee Pollen product is marketed as a dietary supplement used as a weight loss aid and is packaged in bottles of 60 capsules.  The affected Classic Zi Xiu Tang with UPC 6937000700019, includes the following lot numbers - lots 04/15/2012, 05/15/2012, 06/15/2012 and 07/15/2012. Classic Zi Xiu Tang was distributed Nationwide to consumers and distributors.  The products were distributed from May 1, 2012 to October 17, 2012.

The Ultimate Formula product is also marketed as a dietary supplement used as a weight loss aid and is packaged in bottles of 48 capsules.  The affected Ultimate Formula with UPC 793573041401, includes the following lot numbers – 05/25/2012, 07/29/2012 and 08/05/2012.  The Ultimate Formula was distributed Nationwide to consumers and distributors.  The products were distributed from May 1, 2012 to October 17, 2012.

Zi Xiu Success, LLC is notifying its distributors and customers by letter and is arranging for return of all recalled products.  Consumers and distributors that have product which is being recalled should stop using the products and return the product to Zi Xiu Success, LLC.

Zi Xiu Success, LLC regrets any inconvenience to their customers.  This recall is being voluntarily conducted out of concern for the health and safety of consumers.

Consumers with questions regarding this recall can contact Zi Xiu Success, LLC at (800) 764-0120 or info@zixiutangsuccess.com  Monday - Friday from 9:00am-5:00pm Est.   Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Media Contact: Amber Krum Zi Xiu Tang Success, LLC, 8007640120, info@zixiutangsuccess.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Zi Xiu Tang Success, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Icahn Issues Statement Regarding Amylin Pharmaceuticals
2. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
3. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
4. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
5. BD Issues 2011 Sustainability Report
6. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
7. OncoSec Medical Issues Letter to Shareholders
8. FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet
9. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
10. MLB All-Star Pitcher CC Sabathia Issues Fast Relief Challenge to Generate Donations for the American Red Cross
11. Carl Icahn Issues Letter To Howard Solomon Of Forest Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
Breaking Medicine News(10 mins):